The structures differ from real human embryos in many ways, and cannot develop into them because they lack several embryonic tissues, as well as the supporting yolk sac and placenta needed for further development.
The human stem cells used to derive hematoids can be created from any cell in the body. This means the approach also holds great potential for personalised medicine in the future, by allowing the production of blood that is fully compatible with a patient’s own body.